Solid Biosciences Inc.
(NASDAQ : SLDB)

( )
SLDB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.83%191.561.2%$567.63m
GILDGilead Sciences, Inc.
-0.97%70.490.9%$501.34m
BIIBBiogen Inc.
-1.94%318.901.3%$457.42m
CELGCelgene Corporation
-4.05%71.021.2%$422.10m
ILMNIllumina, Inc.
-5.73%310.393.5%$402.00m
REGNRegeneron Pharmaceuticals, Inc.
-2.83%346.562.6%$291.08m
VRTXVertex Pharmaceuticals Incorporated
-4.27%172.851.9%$281.35m
ALXNAlexion Pharmaceuticals, Inc.
-3.92%118.602.0%$203.65m
AAgilent Technologies, Inc.
-4.12%64.501.5%$169.81m
LGNDLigand Pharmaceuticals Incorporated
-1.97%155.4723.3%$152.44m
EXASExact Sciences Corporation
-8.54%68.2525.3%$149.11m
SRPTSarepta Therapeutics, Inc.
-3.70%120.8216.4%$136.29m
ECYTEndocyte, Inc.
-0.04%23.552.0%$123.58m
INCYIncyte Corporation
-4.80%62.862.5%$111.57m
BMRNBioMarin Pharmaceutical Inc.
-2.72%93.074.3%$110.69m

Company Profile

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey Zarur, and Gilad Hayeem in March 2013 and is headquartered in Cambridge, MA.